Biocompatibility of injectable calcium phosphate cement

Miao J,Liu CR,Xia Q
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.48.015
2007-01-01
Abstract:Aim: Calcium phosphate cement is a novel bone graft material, and its modification has become one of the hot topic in recent researches. This study was designed to prepare injectable calcium phosphate cement (ICPC) by changing the rheology of calcium phosphate cement, evaluate bicompatibility and apply ICPC on minimal invasion in clinics. Methods: The experiment was carried out in the Orthopaedics Institute of Tianjin Hospital from October 2006 to January 2007. 1 ICPC included solid phase (CaCO3 and calcium phosphate, etc) and liquid phase (sodium phosphate solution). 2 Fourteen New Zealand rabbits, weighing 2.0-3.5 kg, of either genders, were used in the study. All the animals were managed in accordance with the ethical standard of animals. 3 Marrow stroma cells were co-cultured with ICPC extracting solution or cement specimen. Cell relative growth rate was measured by MTT methods. And cell-cytotoxic reaction was also graded. Cell morphology and activity were detected under light microscope and scanning electron microscope. ICPC specimens were implanted in rabbit muscle to evaluate inflammation reaction and fibrous capsule formation. Hemolytic test and pyrogen test were performed in the ICPC extracting solution. Results: All the 14 New Zealand rabbits were involved in the result analysis. Marrow stroma cells grew well with toxicity rank of zero to one grade when co-cultured with ICPC extracting solution or cement specimen. The hemolysis rate was no more than 0.05% and no pyrogenetic reaction occurred after injecting extracting solution into vein of rabbit ears. ICPC specimens were implanted in rabbit muscle for 24 weeks. Lymphocytes infiltrating and fibular capsule formation were found in the early stage, while lymphocytes decreased or disappeared and capsule became stable in the late stage, without the presence of thickening capsule or leukocytic infiltration. Conclusion: ICPC has excellent biocompatibility and fits cytotoxicity requirement for biomaterials, which will be implanted in human. So ICPC can be used safely in clinics without harm to human body.
What problem does this paper attempt to address?